218 related articles for article (PubMed ID: 22892718)
1. Reduction of N-acetylaspartate in the medial prefrontal cortex correlated with symptom severity in obsessive-compulsive disorder: meta-analyses of (1)H-MRS studies.
Aoki Y; Aoki A; Suwa H
Transl Psychiatry; 2012 Aug; 2(8):e153. PubMed ID: 22892718
[TBL] [Abstract][Full Text] [Related]
2. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
[TBL] [Abstract][Full Text] [Related]
3. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
[TBL] [Abstract][Full Text] [Related]
5. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.
Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z
Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427
[TBL] [Abstract][Full Text] [Related]
6. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
[TBL] [Abstract][Full Text] [Related]
7. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
[TBL] [Abstract][Full Text] [Related]
8. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
[TBL] [Abstract][Full Text] [Related]
9. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
Park SE; Choi NG; Jeong GW
Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
[TBL] [Abstract][Full Text] [Related]
10. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
Fan S; Cath DC; van den Heuvel OA; van der Werf YD; Schöls C; Veltman DJ; Pouwels PJW
Psychoneuroendocrinology; 2017 Mar; 77():211-217. PubMed ID: 28104554
[TBL] [Abstract][Full Text] [Related]
12. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
[TBL] [Abstract][Full Text] [Related]
13. Anterior thalamic radiation structural and metabolic changes in obsessive-compulsive disorder: A combined DTI-MRS study.
Wang R; Fan Q; Zhang Z; Chen Y; Zhu Y; Li Y
Psychiatry Res Neuroimaging; 2018 Jul; 277():39-44. PubMed ID: 29807209
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of brain volume changes in obsessive-compulsive disorder.
Rotge JY; Guehl D; Dilharreguy B; Tignol J; Bioulac B; Allard M; Burbaud P; Aouizerate B
Biol Psychiatry; 2009 Jan; 65(1):75-83. PubMed ID: 18718575
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
Sumitani S; Harada M; Kubo H; Ohmori T
Psychiatry Res; 2007 Jan; 154(1):85-92. PubMed ID: 17208418
[TBL] [Abstract][Full Text] [Related]
16. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
[TBL] [Abstract][Full Text] [Related]
17. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
Yang YS; Smucny J; Zhang H; Maddock RJ
Neuroimage Clin; 2023; 39():103461. PubMed ID: 37406595
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.
Biria M; Cantonas LM; Banca P
Curr Top Behav Neurosci; 2021; 49():231-268. PubMed ID: 33751502
[TBL] [Abstract][Full Text] [Related]
19. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.
Russell A; Cortese B; Lorch E; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S31-8. PubMed ID: 12880498
[TBL] [Abstract][Full Text] [Related]
20. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
